Treatment pattern of type 2 diabetes differs in two German regions and with patients' socioeconomic position

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Tamayo, Teresa ^a   Claessen, Heiner ^a   Rückert, Ina Maria ^b   Maier, Werner ^b   Schunk, Michaela ^b   Meisinger, Christine ^b   Mielck, Andreas ^b   Holle, Rolf ^b   Thorand, Barbara ^b,c   Narres, Maria ^a   Moebus, Susanne ^d   Mahabadi, Amir Abbas ^e   Pundt, Noreen ^d   Krone, Bastian ^d   Slomiany, Uta ^d   Erbel, Raimund ^e   Jöckel, Karl Heinz ^d   Rathmann, Wolfgang ^a   Icks, Andrea ^a,f  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIMEPIRIDE; HYPERGLYCEMIC AGENT; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE DURATION; EDUCATION; FEMALE; GERMANY; HEALTH INSURANCE; HUMAN; HYPERGLYCEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROBABILITY; SELF REPORT; SOCIOECONOMICS; AGED; DIABETES MELLITUS, TYPE 2; ECONOMICS;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; SOCIOECONOMIC FACTORS;

EID: 84902668545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099773     Document Type: Article

References (35)

1. Rosenthal T (2012) Geographic variation in health care. Annu Rev Med 63:493-509.
2. Zuckerman S, Waidmann T, Berenson R, Hadley J (2010) Clarifying sources of geographic differences in Medicare spending. N Engl J Med 363:54-62.
3. Waugh N, Cummins E, Royle P, Clar C, Marien M, et al. (2010) Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. Health Technol Assess 14:1-248.
4. Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P (2012) Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 156:218-231. Erratum in: Ann Intern Med 156:756.
5. Régie de l'assurancemaladie du Quebec. Liste de medicaments. Available: https://www.prod.ramq.gouv.qc.ca/DPI/PO/Commun/PDF/Liste-Med/Liste- Med/liste-med-2012-07-16-fr.pdf Accessed 21 May 2014.
6. Dorais M, Lelorier J (2008) Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidiones (TZDS). Can J Clin Pharmacol 15:e15-21. (Pubitemid 351162495)
7. Gesundheitsberichterstattung des Bundes. Available: http://www.gbe-bund. de Accessed 21 May 2014.
8. Oduncu FS (2013) Priority-setting, rationing and cost-effectiveness in the German health care system. Med Health Care Philos; 16:237-339.
9. Busse R (2004) Disease management programs in Germanys statutory health insurance system. Health Affairs; 23:56-67.
10. Kassenärztliche Vereinigung Nordrhein. Available: http://www.kvno.de/downloads/vertraege/dmp-diab2-vertrag.pdf Accessed 21 May 2014.
11. Schipf S, Werner A, Tamayo T, Holle R, Schunk M, et al. (2012) Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74years old individuals: Results from six population-based studies in Germany (DIABCORE Consortium). Diabet Med; 29:e88-e95.
12. Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, et al. (2003) High prevalence of undiagnosed diabetes mellitus in southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182-189. (Pubitemid 36343881)
13. Stang A, Moebus S, Dragano N, Beck EM, Möhlenkamp S, et al. (2005) Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: Identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20:489-496. (Pubitemid 40933925)
14. Meisinger C, Strassburger K, Heier M, Thorand B, Baumeister SE, et al. (2010) Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59- year-old individuals in southern Germany: the KORA F4 Study. Diabet Med 27:360-362.
15. Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, et al. (2009) Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of the Heinz Nixdorf Recall Study. Diabetologia 52:81-89.
16. Vonneilich N, Jöckel KH, Erbel R, Klein J, Dragano N, et al. (2012) The mediating effect of social relationships on the association between socioeconomic status and subjective health - results from the Heinz Nixdorf Recall cohort study. BMC Public Health 12:285.
17. Meisinger C, Döring A, Stöckl D, Thorand B, Kowall B, et al. (2012) Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study. PLoS One 7:e37180.
18. Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, et al. (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144:212-218. (Pubitemid 34879641)
19. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F, Geurts JJ (1997) Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet 349: 1655-1659. (Pubitemid 27234807)
20. Icks A, Rathmann W, Haastert B, Giani G (2006) Trends of hospitalization and association with sociodemographic factors in the diabetic and the non-diabetic population in Germany: National Health Surveys 1990-92 and 1998. Am J Public Health 96:1656-1661. (Pubitemid 44300931)
21. Roskam AJ, Kunst AE, Van Oyen H, Demarest S, Klumbiene J, et al. (2010) Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int J Epidemiol 39:392-404.
22. Mielck A, Kiess R, von dem Knesebeck O, Stirbu I, Kunst AE (2009) Association between forgone care and household income among the elderly in five western European countries - analyses based on survey data from the SHARE-study. BMC Health Serv Res 9:52.
23. Maier W, Holle R, Hunger M, Peters A, Meisinger C, et al. (2013) The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med 30:e78-86.
24. Kraus L, Augustin R (2001) Measuring alcohol consumption and alcohol-related problems: comparison of responses from self-administered questionnaires and telephone interviews. Addiction 96:459-71. (Pubitemid 32217485)
25. Zou G. (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol http://www.ncbi.nlm.nih.gov/pubmed/ 15033648159:702-706.
26. Zocchetti C, Consonni D, Bertazzi PA (1997) Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol 26:220-223. (Pubitemid 27129588)
27. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364-1379.
28. Gude D (2012) Red carpeting the newer antidiabetics. J Pharmacol Pharmacother 3:127-131.
29. Sundmacher L, Kimmerle J, Latzitis N, Busse R (2011) [Amenable mortality in Germany: spatial distribution and regional concentrations]. Gesundheitswesen. 73:229-237.
30. Meisinger C, Heier M, Völzke H, Löwel H, Mitusch R, et al. (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24:293-299. (Pubitemid 43348240)
31. Hagen B, Köhler J, Kretschmann J, Groos S, Weber A, et al. (2012) Analyse regionaler Distanzunterschiede im DMP Diabetes mellitus Typ 2, Arbeitspapier Nr. 5/2012, DMP Projektbüro des Zentralinstitutes für die Kassenärztliche Versorgung, Köln.
32. Nordin M, Dackehag M, Gerdtham UG (2013) Socioeconomic inequalities in drug utilization for Sweden: Evidence from linked survey and register data. Soc Sci Med 77: 106-117
33. Rabi DM, Edwards AL, Svenson LW, Sargious PM, Norton P, et al. (2007) Clinical and medication profiles stratified by household income in patients referred for diabetes care. Cardiovasc Diabetol 6:11.
34. Koller D, Hoffmann F, Maier W, Tholen K, Windt R, et al. (2013) Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany. Infection 41:121-127.
35. Ozegowski S, Sundmacher L (2014) Understanding the gap between need and utilization in outpatient care - The effect of supply-side determinants on regional inequities. Health policy 114:54-63.